Study Favors Masimo’s (MASI) SedLine for Better Patient Outcome Posted byZacks Equity Research December 14, 2021 Leave a comment on Study Favors Masimo’s (MASI) SedLine for Better Patient Outcome Masimo’s (MASI) SedLine is expected to aid in the early identification of patients who are at risk of developing POD.